INCIDENTAL HEPATIC STEATOSIS IDENTIFIED ON ULTRASOUND IN PATIENTS UNDERGOING CHOLECYSTECTOMY: HIGH PREVALENCE AND INSUFFICIENT INVESTIGATIVE AND CLINICAL MANAGEMENT
ABSTRACT Background: Steatotic liver disease (SLD) affects about 1 billion people globally, making its proper management essential to prevent progression to more severe stages. Objective: The aim of this study was to evaluate medical management concerning hepatic steatosis incidentally identified...
Saved in:
| Main Authors: | Heloísa Mello TRAPP, Paulo André Bispo MACHADO-JÚNIOR, Silvania Klug PIMENTEL |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia (IBEPEGE)
2025-05-01
|
| Series: | Arquivos de Gastroenterologia |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032025000100502&lng=en&tlng=en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association between cholecystectomy and the risk of new-onset metabolic dysfunction-associated steatotic liver disease: a risk-stratified cohort study
by: Hong Jae Jeon, et al.
Published: (2025-08-01) -
MOFI-FL, a novel score for detecting hepatic steatosis and predicting cardiometabolic mortality
by: Juan Reyes-Barrera, et al.
Published: (2025-08-01) -
From adiposity to steatosis: metabolic dysfunction-associated steatotic liver disease, a hepatic expression of metabolic syndrome – current insights and future directions
by: Bruno Basil, et al.
Published: (2024-12-01) -
Predictors of hepatic steatosis in living liver donors
by: M. G. Minina, et al.
Published: (2022-12-01) -
Pathogenic Mechanisms of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Associated Hepatocellular Carcinoma
by: Toru Nakamura, et al.
Published: (2025-03-01)